Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A
- PMID: 11474113
- DOI: 10.1126/science.1061781
Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A
Retraction in
-
Retraction.Science. 2005 Jan 14;307(5707):206. doi: 10.1126/science.307.5707.206b. Science. 2005. PMID: 15653487 No abstract available.
Abstract
Although the biological actions of the cell membrane and serum lipid lysophosphatidylcholine (LPC) in atherosclerosis and systemic autoimmune disease are well recognized, LPC has not been linked to a specific cell-surface receptor. We show that LPC is a high-affinity ligand for G2A, a lymphocyte-expressed G protein-coupled receptor whose genetic ablation results in the development of autoimmunity. Activation of G2A by LPC increased intracellular calcium concentration, induced receptor internalization, activated ERK mitogen-activated protein kinase, and modified migratory responses of Jurkat T lymphocytes. This finding implicates a role for LPC-G2A interaction in the etiology of inflammatory autoimmune disease and atherosclerosis.
Comment in
-
Immunology. The push-me pull-you of T cell activation.Science. 2001 Jul 27;293(5530):618-9. doi: 10.1126/science.1063516. Science. 2001. PMID: 11474091 No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous
